未登录

U

Usama A. Fahmy

r&d department

H指数:32

被引数:2,898

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Celastrol Mitigates Colistin-Induced Renal Toxicity in Rats via Modulating Nrf-2/HO-1 and NF-κB Signaling Pathways

Celastrol通过调节Nrf-2/HO-1和NF-κB信号通路减轻大鼠的粘菌素诱导的肾毒性

Journal of Biochemical and Molecular Toxicology

IF2.8

2025-12-120

PRE

Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells (vol 13, 20, 2021)

IF5.5

2025-01-220

OAAI

Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. Pharmaceutics (vol 14, 227, 2022)

IF5.5

2025-01-140

OAAI

RETRACTION: Ceftriaxone and Melittin Synergistically Promote Wound Healing in Diabetic Rats

IF5.5

2024-09-050

OAAI

Omeprazole Prevents Colistin-Induced Nephrotoxicity in Rats: Emphasis on Oxidative Stress, Inflammation, Apoptosis and Colistin Accumulation in Kidneys (Vol 15, 782, 2022)

PHARMACEUTICALS

IF4.8

2024-04-220

OAAI

RETRACTION: Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation (Retraction of Vol 154, art no 113619, 2022)

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2024-03-010

OAAI

RETRACTION: Chitosan-Based Microparticles Enhance Ellagic Acid's Colon Targeting and Proapoptotic Activity (Retraction of Vol 12, art no 652, 2020)

IF5.5

2024-01-300

OAAI

RETRACTION: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment. (Retraction of Vol 13, art no 783, 2021)

IF5.5

2024-01-300

OAAI

RETRACTION: Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells (Retraction of Vol 12, art no 346, 2020)

IF5.5

2024-01-300

OAAI

RETRACTION: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation (Retraction of Vol 12, art no 485, 2020)

IF5.5

2024-01-290

OAAI

RETRACTION: Omega-3 Self-Nanoemulsion Role in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats (Retraction of Vol 12, art no 140, 2020)

IF5.5

2024-01-290

OAAI

RETRACTION: Awan et al. The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells (Retraction of Vol 12, art no 597, 2020)

IF5.5

2024-01-290

OAAI

RETRACTION: Fluoxetine Ecofriendly Nanoemulsion Enhances Wound Healing in Diabetic Rats: In Vivo Efficacy Assessment (Retraction of Vol 14, art no 1133, 2022)

IF5.5

2024-01-230

OAAI

RETRACTION: Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells. (Retraction of Vol 12, art no 761, 2020)

IF5.5

2024-01-230

OAAI

RETRACTION: Amitriptyline-Based Biodegradable PEG-PLGA Self-Assembled Nanoparticles Accelerate Cutaneous Wound Healing in Diabetic Rats (Retraction of Vol 14, art no 1792, 2022)

IF5.5

2024-01-220

OAAI

RETRACTION: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route (Retraction of Vol 10, art no 1270, 2020)

IF4.3

2024-01-120

OAAI

Dihydromyricetin protects against gentamicin-induced nephrotoxicity via upregulation of renal SIRT3 and PAX2

IF5.1

2024-01-013

PRE

Optimized bilosome-based nanoparticles enhance cytotoxic and pro-apoptotic activity of costunolide in LS174T colon cancer cells

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-12-012

OAAI

RETRACTION: Attenuation of Benign Prostatic Hyperplasia by Optimized Tadalafil Loaded Pumpkin Seed Oil-Based Self Nanoemulsion: In Vitro and In Vivo Evaluation (Retraction of Vol 11, art no 640, 2019)

IF5.5

2023-11-220

OAAI

Self-Nanoemulsifying Drug Delivery System of 2-Methoxyestradiol Exhibits Enhanced Anti-Proliferative and Pro-Apoptotic Activities in MCF-7 Breast Cancer Cells (vol 12, 1369, 2022)

IF3.4

2023-06-080

OAAI